pediapharm Chef de file pharmaceutique en pédiatrie au Canada

Canada's Leading Pediatric Pharmaceutical Company

What's new

PEDIAPHARM ANNOUNCES THIRD QUARTER FINANCIAL RESULTS – 73% INCREASE IN REVENUE

Read more >

Pediapharm announces the commercial launch of rupall™ (rupatadine) in canada

Read more >

PEDIAPHARM RECEIVES HEALTH CANADA APPROVAL FOR OTIXAL™

Read more >

Stock – PDP.V